Tenaris Announces 2023 Fourth Quarter and Annual Results
The financial and operational information contained in this press release is based on audited consolidated financial statements presented in
LUXEMBOURG,
Summary of 2023 Fourth Quarter Results
4Q 2023 | 3Q 2023 | 4Q 2022 | |||||||||
Net sales ($ million) | 3,415 | 3,238 | 5 | % | 3,620 | (6 | %) | ||||
Operating income ($ million) | 819 | 868 | (6 | %) | 1,013 | (19 | %) | ||||
Net income ($ million) | 1,146 | 547 | 110 | % | 803 | 43 | % | ||||
Shareholders’ net income ($ million) | 1,129 | 537 | 110 | % | 807 | 40 | % | ||||
Earnings per ADS ($)* | 1.92 | 0.91 | 110 | % | 1.37 | 40 | % | ||||
Earnings per share ($)* | 0.96 | 0.46 | 110 | % | 0.68 | 40 | % | ||||
EBITDA ($ million) | 975 | 1,004 | (3 | %) | 1,269 | (23 | %) | ||||
EBITDA margin (% of net sales) | 28.6 | % | 31.0 | % | 35.1 | % |
*For the calculation of per share and per ADS data we have used average number of shares outstanding excluding treasury shares.
Our sales in the fourth quarter of 2023 rose 5% sequentially, boosted by a high level of shipments to the
Our free cash flow for the quarter amounted to
Summary of 2023 Annual Results
12M 2023 | 12M 2022 | Increase/(Decrease) | ||||
Net sales ($ million) | 14,869 | 11,763 | 26 | % | ||
Operating income ($ million) | 4,316 | 2,963 | 46 | % | ||
Net income ($ million) | 3,958 | 2,549 | 55 | % | ||
Shareholders’ net income ($ million) | 3,918 | 2,553 | 53 | % | ||
Earnings per ADS ($)* | 6.65 | 4.33 | 53 | % | ||
Earnings per share ($)* | 3.32 | 2.16 | 54 | % | ||
EBITDA ($ million) | 4,865 | 3,648 | 33 | % | ||
EBITDA margin (% of net sales) | 32.7 | % | 31.0 | % |
*For the calculation of per share and per ADS data we have used average number of shares outstanding excluding treasury shares.
In 2023, our net sales, EBITDA and net income reached record levels. The year was characterized by a first half, in which prices in the
Operating margins expanded reflecting the higher prices realized on the sales of most of our products, which more than compensated for higher costs of goods sold.
Net income benefited from a net positive deferred tax effect of
Operating cash flow for the year amounted to
Market Background and Outlook
In an environment where oil prices remain relatively stable, oil supply and demand is balanced, and the long term outlook for natural gas, especially LNG, is promising, drilling activity in
After the exceptional levels they reached in the post-Covid recovery, tubular price levels and margins in the
In
Annual Dividend Proposal; Second Tranche of Share Buyback Program
Upon approval of the Company´s annual accounts in
The second
Analysis of 2023 Fourth Quarter Results
Tubes Sales volume (thousand metric tons) | 4Q 2023 | 3Q 2023 | 4Q 2022 | ||||
Seamless | 760 | 744 | 2 | % | 809 | (6 | %) |
Welded | 246 | 169 | 45 | % | 156 | 58 | % |
Total | 1,006 | 913 | 10 | % | 965 | 4 | % |
Tubes | 4Q 2023 | 3Q 2023 | 4Q 2022 | |||||||||
(Net sales - $ million) | ||||||||||||
1,501 | 1,700 | (12 | %) | 2,105 | (29 | %) | ||||||
590 | 608 | (3 | %) | 802 | (26 | %) | ||||||
302 | 231 | 30 | % | 185 | 63 | % | ||||||
805 | 556 | 45 | % | 373 | 116 | % | ||||||
Total net sales ($ million) | 3,198 | 3,095 | 3 | % | 3,466 | (8 | %) | |||||
Operating income ($ million) | 780 | 841 | (7 | %) | 980 | (20 | %) | |||||
Operating margin (% of sales) | 24.4 | % | 27.2 | % | 28.3 | % |
Net sales of tubular products and services increased 3% sequentially but declined 8% year on year. Volumes increased 10% sequentially but average selling prices decreased 6%. In
Operating income from tubular products and services, amounted to
Others | 4Q 2023 | 3Q 2023 | 4Q 2022 | |||||||
Net sales ($ million) | 217 | 143 | 52 | % | 154 | 41 | % | |||
Operating income ($ million) | 39 | 27 | 45 | % | 33 | 19 | % | |||
Operating margin (% of sales) | 18.1 | % | 19.0 | % | 21.4 | % |
Net sales of other products and services increased 52% sequentially and 41% year on year. The sequential increase is mainly explained by the consolidation of sales in
Selling, general and administrative expenses, or SG&A, amounted to
Other operating result amounted to a
Financial results were a gain of
Equity in earnings of non-consolidated companies generated a gain of
Income tax result amounted to a gain of
Cash Flow and Liquidity of 2023 Fourth Quarter
Net cash provided by operations during the fourth quarter of 2023 was
With capital expenditures of
Following dividend payments of
Analysis of 2023 Annual Results
Net sales ($ million) | 12M 2023 | 12M 2022 | Increase/(Decrease) | |||||
Tubes | 14,185 | 95 | % | 11,133 | 95 | % | 27 | % |
Others | 684 | 5 | % | 630 | 5 | % | 9 | % |
Total | 14,869 | 11,763 | 26 | % |
Tubes Sales volume (thousand metric tons) | 12M 2023 | 12M 2022 | Increase/(Decrease) | |
Seamless | 3,189 | 3,146 | 1 | % |
Welded | 953 | 387 | 146 | % |
Total | 4,141 | 3,533 | 17 | % |
Tubes | 12M 2023 | 12M 2022 | Increase/(Decrease) | |||
(Net sales - $ million) | ||||||
7,572 | 6,796 | 11 | % | |||
3,067 | 2,213 | 39 | % | |||
1,055 | 867 | 22 | % | |||
2,491 | 1,257 | 98 | % | |||
Total net sales ($ million) | 14,185 | 11,133 | 27 | % | ||
Operating income ($ million) | 4,183 | 2,867 | 46 | % | ||
Operating margin (% of sales) | 29.5 | % | 25.8 | % |
Net sales of tubular products and services increased 27% to
Operating results from tubular products and services, amounted to a gain of
Others | 12M 2023 | 12M 2022 | Increase/(Decrease) | |||
Net sales ($ million) | 684 | 630 | 9 | % | ||
Operating income ($ million) | 133 | 96 | 39 | % | ||
Operating margin (% of sales) | 19.5 | % | 15.2 | % |
Net sales of other products and services increased 9% from
Operating results from other products and services, amounted to a gain of
Selling, general and administrative expenses, or SG&A, amounted to
Financial results amounted to a gain of
2023 results are mainly derived from net foreign exchange gains of
Equity in earnings of non-consolidated companies generated a gain of
Income tax charge amounted to
Cash Flow and Liquidity of 2023
Net cash provided by operations in 2023 was
With capital expenditures of
Following dividend payments of
Conference call
To listen to the conference please join through one of the following options:
ir.tenaris.com/events-and-presentations or
https://edge.media-server.com/mmc/p/384xrvok
If you wish to participate in the Q&A session please register at the following link:
https://register.vevent.com/register/BIdf892e810d2749faba59c1f70a41aba7
Please connect 10 minutes before the scheduled start time.
A replay of the conference call will also be available on our webpage at:
ir.tenaris.com/events-and-presentations
Some of the statements contained in this press release are “forward-looking statements”. Forward-looking statements are based on management’s current views and assumptions and involve known and unknown risks that could cause actual results, performance or events to differ materially from those expressed or implied by those statements. These risks include but are not limited to risks arising from uncertainties as to future oil and gas prices and their impact on investment programs by oil and gas companies.
Consolidated Income Statement | ||||||||
(all amounts in thousands of |
Three-month period ended |
Twelve-month period ended |
||||||
2023 | 2022 | 2023 | 2022 | |||||
Net sales | 3,414,930 | 3,620,210 | 14,868,860 | 11,762,526 | ||||
Cost of sales | (2,120,591 | ) | (2,063,969 | ) | (8,668,915 | ) | (7,087,739 | ) |
Gross profit | 1,294,339 | 1,556,241 | 6,199,945 | 4,674,787 | ||||
Selling, general and administrative expenses | (470,542 | ) | (454,478 | ) | (1,919,307 | ) | (1,634,575 | ) |
Impairment charge | - | (76,725 | ) | - | (76,725 | ) | ||
Other operating income (expense), net | (4,834 | ) | (11,987 | ) | 35,770 | (212 | ) | |
Operating income | 818,963 | 1,013,051 | 4,316,408 | 2,963,275 | ||||
Finance income | 63,621 | 37,756 | 213,474 | 80,020 | ||||
Finance cost | (19,759 | ) | (20,237 | ) | (106,862 | ) | (45,940 | ) |
Other financial results | 49,249 | 18,127 | 114,365 | (40,120 | ) | |||
Income before equity in earnings of non-consolidated companies and income tax | 912,074 | 1,048,697 | 4,537,385 | 2,957,235 | ||||
Equity in earnings of non-consolidated companies | 56,859 | 12,701 | 95,404 | 208,702 | ||||
Income before income tax | 968,933 | 1,061,398 | 4,632,789 | 3,165,937 | ||||
Income tax | 176,848 | (258,226 | ) | (674,956 | ) | (617,236 | ) | |
Income for the period | 1,145,781 | 803,172 | 3,957,833 | 2,548,701 | ||||
Attributable to: | ||||||||
Shareholders' equity | 1,129,098 | 807,318 | 3,918,065 | 2,553,280 | ||||
Non-controlling interests | 16,683 | (4,146 | ) | 39,768 | (4,579 | ) | ||
1,145,781 | 803,172 | 3,957,833 | 2,548,701 |
Consolidated Statement of Financial Position | ||||||
(all amounts in thousands of |
At |
At |
||||
ASSETS | ||||||
Non-current assets | ||||||
Property, plant and equipment, net | 6,078,179 | 5,556,263 | ||||
Intangible assets, net | 1,377,110 | 1,332,508 | ||||
Right-of-use assets, net | 132,138 | 111,741 | ||||
Investments in non-consolidated companies | 1,608,804 | 1,540,646 | ||||
Other investments | 405,631 | 119,902 | ||||
Deferred tax assets | 789,615 | 208,870 | ||||
Receivables, net | 185,959 | 10,577,436 | 211,720 | 9,081,650 | ||
Current assets | ||||||
Inventories, net | 3,921,097 | 3,986,929 | ||||
Receivables and prepayments, net | 228,819 | 183,811 | ||||
Current tax assets | 256,401 | 243,136 | ||||
Trade receivables, net | 2,480,889 | 2,493,940 | ||||
Derivative financial instruments | 9,801 | 30,805 | ||||
Other investments | 1,969,631 | 438,448 | ||||
Cash and cash equivalents | 1,637,821 | 10,504,459 | 1,091,527 | 8,468,596 | ||
Total assets | 21,081,895 | 17,550,246 | ||||
EQUITY | ||||||
Shareholders' equity | 16,842,972 | 13,905,709 | ||||
Non-controlling interests | 187,465 | 128,728 | ||||
Total equity | 17,030,437 | 14,034,437 | ||||
LIABILITIES | ||||||
Non-current liabilities | ||||||
Borrowings | 48,304 | 46,433 | ||||
Lease liabilities | 96,598 | 83,616 | ||||
Derivative financial instruments | 255 | - | ||||
Deferred tax liabilities | 631,605 | 269,069 | ||||
Other liabilities | 271,268 | 230,142 | ||||
Provisions | 101,453 | 1,149,483 | 98,126 | 727,386 | ||
Current liabilities | ||||||
Borrowings | 535,133 | 682,329 | ||||
Lease liabilities | 37,835 | 28,561 | ||||
Derivative financial instruments | 10,895 | 7,127 | ||||
Current tax liabilities | 488,277 | 376,240 | ||||
Other liabilities | 422,645 | 260,614 | ||||
Provisions | 35,959 | 11,185 | ||||
Customer advances | 263,664 | 242,910 | ||||
Trade payables | 1,107,567 | 2,901,975 | 1,179,457 | 2,788,423 | ||
Total liabilities | 4,051,458 | 3,515,809 | ||||
Total equity and liabilities | 21,081,895 | 17,550,246 |
Consolidated Statement of Cash Flows | ||||||||
Three-month period ended |
Twelve-month period ended |
|||||||
(all amounts in thousands of |
2023 | 2022 | 2023 | 2022 | ||||
Cash flows from operating activities | ||||||||
Income for the year | 1,145,781 | 803,172 | 3,957,833 | 2,548,701 | ||||
Adjustments for: | ||||||||
Depreciation and amortization | 156,347 | 179,135 | 548,510 | 607,723 | ||||
Impairment charge | - | 76,725 | - | 76,725 | ||||
Income tax accruals less payments | (277,559 | ) | 139,061 | (143,391 | ) | 257,651 | ||
Equity in earnings of non-consolidated companies | (56,859 | ) | (12,701 | ) | (95,404 | ) | (208,702 | ) |
Interest accruals less payments, net | (8,554 | ) | (3,672 | ) | (53,480 | ) | 1,480 | |
Changes in provisions | (651 | ) | 7,164 | 21,284 | 16,433 | |||
Reclassification of currency translation adjustment reserve | (878 | ) | - | (878 | ) | (71,252 | ) | |
Changes in working capital | (65,697 | ) | (682,115 | ) | 182,428 | (2,131,245 | ) | |
Others, including net exchange differences | (56,195 | ) | 17,173 | (21,829 | ) | 69,703 | ||
Net cash provided by operating activities | 835,735 | 523,942 | 4,395,073 | 1,167,217 | ||||
Cash flows from investing activities | ||||||||
Capital expenditures | (166,820 | ) | (107,646 | ) | (619,445 | ) | (378,446 | ) |
Changes in advance to suppliers of property, plant and equipment | 834 | (13,108 | ) | 1,736 | (18,901 | ) | ||
Acquisition of subsidiaries, net of cash acquired | (161,238 | ) | - | (265,657 | ) | (4,082 | ) | |
Investment in companies under cost method | (1,126 | ) | - | (1,126 | ) | - | ||
Additions to associated companies | - | - | (22,661 | ) | - | |||
Loan to joint-ventures | (1,092 | ) | - | (3,754 | ) | - | ||
Proceeds from disposal of property, plant and equipment and intangible assets | 3,858 | 1,690 | 12,881 | 48,458 | ||||
Dividends received from non-consolidated companies | 25,268 | 20,674 | 68,781 | 66,162 | ||||
Changes in investments in securities | 740,153 | 38,079 | (1,857,272 | ) | 123,254 | |||
Net cash provided by (used in) investing activities | 439,837 | (60,311 | ) | (2,686,517 | ) | (163,555 | ) | |
Cash flows from financing activities | ||||||||
Dividends paid | (235,128 | ) | (200,658 | ) | (636,511 | ) | (531,242 | ) |
Dividends paid to non-controlling interest in subsidiaries | - | - | (18,967 | ) | (10,432 | ) | ||
Changes in non-controlling interests | - | 2,099 | 3,772 | (1,407 | ) | |||
Acquisition of treasury shares | (213,739 | ) | - | (213,739 | ) | - | ||
Payments of lease liabilities | (15,524 | ) | (13,560 | ) | (51,492 | ) | (52,396 | ) |
Proceeds from borrowings | 365,455 | 161,785 | 1,723,677 | 1,511,503 | ||||
Repayments of borrowings | (406,774 | ) | (300,783 | ) | (1,931,747 | ) | (1,094,370 | ) |
Net cash used in financing activities | (505,711 | ) | (351,117 | ) | (1,125,007 | ) | (178,344 | ) |
Increase in cash and cash equivalents | 769,861 | 112,514 | 583,549 | 825,318 | ||||
Movement in cash and cash equivalents | ||||||||
At the beginning of the year | 864,012 | 990,803 | 1,091,433 | 318,067 | ||||
Effect of exchange rate changes | (17,276 | ) | (11,883 | ) | (58,385 | ) | (51,952 | ) |
Increase in cash and cash equivalents | 769,861 | 112,514 | 583,549 | 825,318 | ||||
At |
1,616,597 | 1,091,434 | 1,616,597 | 1,091,433 |
Exhibit I – Alternative performance measures
Alternative performance measures should be considered in addition to, not as substitute for or superior to, other measures of financial performance prepared in accordance with IFRS.
EBITDA, Earnings before interest, tax, depreciation and amortization.
EBITDA provides an analysis of the operating results excluding depreciation and amortization and impairments, as they are recurring non-cash variables which can vary substantially from company to company depending on accounting policies and the accounting value of the assets. EBITDA is an approximation to pre-tax operating cash flow and reflects cash generation before working capital variation. EBITDA is widely used by investors when evaluating businesses (multiples valuation), as well as by rating agencies and creditors to evaluate the level of debt, comparing EBITDA with net debt.
EBITDA is calculated in the following manner:
EBITDA = Net income for the period + Income tax charges +/- Equity in Earnings (losses) of non-consolidated companies +/- Financial results + Depreciation and amortization +/- Impairment charges/(reversals)
EBITDA is a non-IFRS alternative performance measure.
(all amounts in thousands of |
Three-month period ended |
Twelve-month period ended |
||||||
2023 | 2022 | 2023 | 2022 | |||||
Income for the period | 1,145,781 | 803,172 | 3,957,833 | 2,548,701 | ||||
Income tax charge / (credit) | (176,848 | ) | 258,226 | 674,956 | 617,236 | |||
Equity in earnings of non-consolidated companies | (56,859 | ) | (12,701 | ) | (95,404 | ) | (208,702 | ) |
Financial results | (93,111 | ) | (35,646 | ) | (220,977 | ) | 6,040 | |
Depreciation and amortization | 156,347 | 179,135 | 548,510 | 607,723 | ||||
Impairment charge | - | 76,725 | - | 76,725 | ||||
EBITDA | 975,310 | 1,268,911 | 4,864,918 | 3,647,723 |
Free Cash Flow
Free cash flow is a measure of financial performance, calculated as operating cash flow less capital expenditures. FCF represents the cash that a company is able to generate after spending the money required to maintain or expand its asset base.
Free cash flow is calculated in the following manner:
Free cash flow = Net cash (used in) provided by operating activities - Capital expenditures.
Free cash flow is a non-IFRS alternative performance measure.
(all amounts in thousands of |
Three-month period ended |
Twelve-month period ended |
||||||
2023 | 2022 | 2023 | 2022 | |||||
Net cash provided by operating activities | 835,735 | 523,942 | 4,395,073 | 1,167,217 | ||||
Capital expenditures | (166,820 | ) | (107,646 | ) | (619,445 | ) | (378,446 | ) |
Free cash flow | 668,915 | 416,296 | 3,775,628 | 788,771 |
This is the net balance of cash and cash equivalents, other current investments and fixed income investments held to maturity less total borrowings. It provides a summary of the financial solvency and liquidity of the company. Net cash / (debt) is widely used by investors and rating agencies and creditors to assess the company’s leverage, financial strength, flexibility and risks.
Net cash/ debt is calculated in the following manner:
Net cash = Cash and cash equivalents + Other investments (Current and Non-Current)+/- Derivatives hedging borrowings and investments - Borrowings (Current and Non-Current).
Net cash/debt is a non-IFRS alternative performance measure.
(all amounts in thousands of |
Year ended |
|||
2023 | 2022 | |||
Cash and cash equivalents | 1,637,821 | 1,091,527 | ||
Other current investments | 1,969,631 | 438,448 | ||
Non-current investments | 398,220 | 113,574 | ||
Derivatives hedging borrowings and investments | - | 6,480 | ||
Current borrowings | (535,133 | ) | (682,329 | ) |
Non-current borrowings | (48,304 | ) | (46,433 | ) |
Net cash / (debt) | 3,422,235 | 921,267 |
Operating working capital days
Operating working capital is the difference between the main operating components of current assets and current liabilities. Operating working capital is a measure of a company’s operational efficiency, and short-term financial health.
Operating working capital days is calculated in the following manner:
Operating working capital days = [(Inventories + Trade receivables – Trade payables – Customer advances) / Annualized quarterly sales ] x 365
Operating working capital days is a non-IFRS alternative performance measure.
(all amounts in thousands of |
Three-month period ended |
|||
2023 | 2022 | |||
Inventories | 3,921,097 | 3,986,929 | ||
Trade receivables | 2,480,889 | 2,493,940 | ||
Customer advances | (263,664 | ) | (242,910 | ) |
Trade payables | (1,107,567 | ) | (1,179,457 | ) |
Operating working capital | 5,030,755 | 5,058,502 | ||
Annualized quarterly sales | 13,659,720 | 14,480,840 | ||
Operating working capital days | 134 | 128 |
Giovanni Sardagna
1-888-300-5432
www.tenaris.com
Source: Tenaris SA